PFIZER INC Remaining Share Repurchase Authorization
PFIZER INC (PFE) had Remaining Share Repurchase Authorization of $3.30 billion as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 · last filed 2026-02-26
- 2025-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $3.30B.
- 2024-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $3.30B.
- 2023-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $3.30B.
- 2022-12-31: Stock Repurchase Program, Remaining Authorized Repurchase Amount $3.30B.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount |
|---|---|
| 2025-12-31 | $3.30B 10-K · filed 2026-02-26 |
| 2024-12-31 | $3.30B 10-K · filed 2025-02-27 |
| 2023-12-31 | $3.30B 10-K · filed 2024-02-22 |
| 2022-12-31 | $3.30B 10-K · filed 2023-02-23 |
| 2021-12-31 | $5.30B 10-K · filed 2022-02-24 |
| 2020-12-31 | $5.30B 10-K · filed 2021-02-25 |
| 2019-12-31 | $5.30B 10-K · filed 2020-02-27 |
| 2019-09-29 | $5.30B 10-Q · filed 2019-11-07 |
| 2019-06-30 | $5.30B 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.30B 10-Q · filed 2019-05-09 |
| 2018-12-31 | $14.20B 10-K · filed 2019-02-28 |
| 2018-09-30 | $9.20B 10-Q · filed 2018-11-08 |
| 2018-07-01 | $10.30B 10-Q · filed 2018-08-09 |
| 2018-04-01 | $10.30B 10-Q · filed 2018-05-10 |
| 2017-12-31 | $16.40B 10-K · filed 2018-02-22 |
| 2016-12-31 | $11.40B 10-K · filed 2017-02-23 |
| 2016-10-02 | $11.40B 10-Q · filed 2016-11-10 |
| 2016-07-03 | $11.40B 10-Q · filed 2016-08-11 |
| 2016-04-03 | $11.40B 10-Q · filed 2016-05-12 |
| 2015-12-31 | $16.40B 10-K · filed 2016-02-29 |
| 2015-07-13 | $5.40B 10-Q · filed 2015-11-05 |
| 2014-12-31 | $11.50B 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |